secwatch.observer — SEC 8-K summary
======================================

Issuer:     DMK PHARMACEUTICALS Corp (—)
CIK:        0000887247
Form:       8-K
Filed at:   2024-01-23T23:59:59+00:00
Accession:  0001999371-24-000734
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DMK Pharmaceuticals amends bylaws to revise stockholder meeting quorum requirements
--------------------------------------------------------------------------------

- Effective January 22, 2024, amended bylaws require holders of at least one-third voting power and one-third of common stock shares for quorum.
- Change applies to all stockholder meetings; previous quorum threshold was different.
- Bylaws amendment filed as Exhibit 3.1 to the 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/887247/000199937124000734/0001999371-24-000734-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/887247/000199937124000734/dmk_8k-012224.htm
  HTML page:      https://secwatch.observer/filing/0001999371-24-000734

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer